From Strict Avoidance to Tailored Therapies: Transforming Food Allergy Care

This activity was originally broadcast in conjunction with AMCP Nexus 2024.

Program Description

People with food allergies need to be vigilant about avoiding their allergens, but this often causes increased stress about safe food options and the availability of rescue medications in case of accidental exposures. These current approaches for the management of severe food-related reactions have their limitations. Ongoing research is targeting both novel immunomodulators and biologic therapy to improve patients' desensitization and tolerance to food allergens and reduce severe reactions. Several organizations have released guidelines for the management of food allergies, and managed care professionals and pharmacists must work to implement their recommendations in clinical practice. Evolving approaches in food allergy management, from strict allergen avoidance to the evolving use of immunomodulators and targeted biologics will be reviewed. Managed care pharmacists should follow these developments as new treatment options become available for patients with food allergies and use key policy recommendations to update protocols and formularies to improve health-related quality of life and outcomes for patients living with food allergies.

Target audience: Managed care pharmacists

Type of activity: Application
Release date: October 21, 2024
Expiration date: October 21, 2025

Time to complete activity: 1.5 hours

Learner level: Intermediate
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Analyze the economic and treatment burden associated with managing food allergies, considering direct and indirect costs, health care system strain, and the impact on families
• Examine the clinical and real-world data for new and emerging agents targeting immunoglobulin E in food allergies and their potential to mitigate symptoms and improve patient outcomes
• Investigate managed care strategies designed to facilitate appropriate access to effective food allergy treatments, considering cost-effectiveness, coverage policies, and improving patient outcomes

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.5 contact hours (0.15 CEU) under the ACPE universal activity number 0290-0000-24-298-H01-P. The activity is available for CE credit through October 21, 2025.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Faculty

Susan M. Wescott, RPh, MBA, has the following relevant financial relationship with a commercial interest to disclose:

Other: Employed by Mayo Clinic as a subcontractor to a pharmacy benefit manager (Alluma)

Ruchi Gupta, MD, MPH, has the following relevant financial relationships with commercial interests to disclose:

Grant/Research Support: Novartis, Genentech

Consultant: Genentech, Novartis, Aimmune Therapeutics, Allergenis, Inc.

Pharmacy Times Continuing Education^™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Dipti Desai, PharmD, MBA, CHCP; Kylie Ferrentino; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms